Follow
Julia An
Title
Cited by
Cited by
Year
Expressing the human cholesteryl ester transfer protein minigene improves diet-induced fatty liver and insulin resistance in female mice
L Zhu, J An, S Chinnarasu, T Luu, YD Pettway, K Fahey, B Litts, HYH Kim, ...
Frontiers in Physiology 12, 799096, 2022
62022
Lethal COVID-19 Associates With RAAS-Induced Inflammation For Multiple Organ Damage Including Mediastinal Lymph Nodes
JW Guarnieri, MJ Topper, K Beigel, JA Haltom, A Chadburn, J Frere, J An, ...
bioRxiv, 2023.10. 08.561395, 2023
32023
Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer
E Ferraro, A Khan, G Plitas, Y Chen, M Ahmed, J An, C Dang, M Robson, ...
Cancer Research 84 (9_Supplement), PO3-04-07-PO3-04-07, 2024
2024
Abstract PO5-16-01: Clinicogenomic analysis reveals genomic associations of brain metastatic tropism in breast cancer
A Safonov, D Smith, E Ferraro, J Shen, I Khatri, R Kumar, J An, M Robson, ...
Cancer Research 84 (9_Supplement), PO5-16-01-PO5-16-01, 2024
2024
Ablation of IFNγ in myeloid cells suppresses liver inflammation and fibrogenesis in mice with hepatic small heterodimer partner (SHP) deletion
L Zhu, B Litts, Y Wang, JA Rein, CL Atzrodt, S Chinnarasu, J An, ...
Molecular Metabolism 83, 101932, 2024
2024
STAT3 inhibition synergizes with epigenetic therapy to suppress glutamine metabolism and clonogenic potential in non-small cell lung cancer
J An, YY Chen, J Park, S Baylin, M Topper
Cancer Research 84 (6_Supplement), 3219-3219, 2024
2024
Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer
A Safonov, A Marra, C Bandlamudi, B O'Leary, B Wubbenhorst, E Moiso, ...
bioRxiv, 2024.02. 05.578934, 2024
2024
Reducing Cardiovascular Disease Risk by Estrogen Treatment After Surgical Menopause in Combination With the Suppression of Interferon Gamma Pathway in Ldlr Null Mice
L Zhu, B Litts, J An, J Rein, S Chinnarasu, MF Linton, JM Stafford
Circulation 148 (Suppl_1), A13763-A13763, 2023
2023
592-P: Exercise Training and a Chow Diet Improve High-Fat Diet (HFD)–Induced Metabolic Disorders via Different Pathways in Female Mice
LIN ZHU, J AN, B LITTS, CL ATZRODT, JM STAFFORD
Diabetes 72 (Supplement_1), 2023
2023
Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC)
PJ McCann, W Mao, M Chaimowitz, E Houthys, R Marillier, S Bansal, J An, ...
Cancer Research 83 (11_Supplement), B032-B032, 2023
2023
IMPROVING MANAGEMENT OF NON-SMALL CELL LUNG CANCER BY TARGETING THE STAT3 PATHWAY IN COMBINATION WITH EPIGENETIC THERAPY
J An
Johns Hopkins University, 2023
2023
LETHAL COVID-19 ASSOCIATES WITH RAAS-INDUCED INFLAMMATION FOR MULTIPLE ORGAN DAMAGE INCLUDING MEDIASTINAL LYMPH NODES (preprint)
JW Guarnieri, M Topper, K Beigel, JA Haltoom, A Chadburn, J Frere, J An, ...
2023
Identification of epigenetic therapy induced tumor antigens to promote proliferation and infiltration of antigen specific T cells in non-small cell lung cancer
J An, V Anagnostou, KA Marrone, VE Velculescu, JR Brahmer, SB Baylin, ...
Cancer Research 82 (12_Supplement), 3278-3278, 2022
2022
463-P: Fuel Expenditure and Deposition in Tissues after Exercise or Low-Fat Diet in Obese Female and Male Mice
J An, L Zhu, S Yu, E Edington, B Litts, JM Stafford
Diabetes 70 (Supplement_1), 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–14